Mercaptopurine 50 MG tablet 25S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1MT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,082
Award facts
- Contract value 100% obligated
- $1,082.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Mercaptopurine 50 mg tablets in quantities of 25 units, with a ceiling value of $1,082.05. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 30, 2026, and performance to be completed in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement that extends through December 2026 and serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in supplying prescription medications, generic drugs, vaccines, and medical supplies to military and veteran healthcare systems. The company has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the DLA and other federal agencies. This particular delivery order for Mercaptopurine, a chemotherapy medication, reflects the company's ongoing role in supporting the Defense Health Agency and military treatment facilities with essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1MT?
SPE2DR26FA1MT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FA1MT worth?
The government has obligated $1,082 on SPE2DR26FA1MT.
Is contract SPE2DR26FA1MT an order under another contract?
Yes. SPE2DR26FA1MT is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1MT competed?
The extent of competition for SPE2DR26FA1MT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award